We have previously demonstrated that the intradermal administration of a DNA vaccine encoding Calreticulin linked to E7 (CRT/E7) via gene gun was able to generate high numbers of E7-specific CD8+ T-cell immune responses and therapeutic anti-tumor effects in vaccinated mice [22]. The gene discussed is CALR; the disease is neoplasm.